Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial.
Crombie N, Doughty HA, Bishop JRB, Desai A, Dixon EF, Hancox JM, Herbert MJ, Leech C, Lewis SJ, Nash MR, Naumann DN, Slinn G, Smith H, Smith IM, Wale RK, Wilson A, Ives N, Perkins GD; RePHILL collaborative group.
Lancet Haematol. 2022 Apr;9(4):e250-e261. doi: 10.1016/S2352-3026(22)00040-0. Epub 2022 Mar 7.
Does this patient have a severe upper gastrointestinal bleed?
Srygley FD, Gerardo CJ, Tran T, Fisher DA.
JAMA. 2012 Mar 14;307(10):1072-9. doi: 10.1001/jama.2012.253.
Pitfalls in the diagnosis of hematuria.
Delanghe J, Speeckaert M, Delanghe S, Oyaert M.
Clin Chem Lab Med. 2023 Apr 24;61(8):1382-1387. doi: 10.1515/cclm-2023-0260. Print 2023 Jul 26.
Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis.
Gallos I, Williams H, Price M, Pickering K, Merriel A, Tobias A, Lissauer D, Gee H, Tunçalp Ö, Gyte G, Moorthy V, Roberts T, Deeks J, Hofmeyr J, Gülmezoglu M, Coomarasamy A.
Health Technol Assess. 2019 Feb;23(9):1-356. doi: 10.3310/hta23090.
[Eosinopenia in 2018].
Gil H, Bouldoires B, Bailly B, Meaux Ruault N, Humbert S, Magy-Bertrand N.
Rev Med Interne. 2019 Mar;40(3):173-177. doi: 10.1016/j.revmed.2018.11.008. Epub 2018 Nov 27.
Carbetocin vs. oxytocin at elective caesarean delivery: a double-blind, randomised, controlled, non-inferiority trial of low- and high-dose regimens.
McDonagh F, Carvalho JCA, Abdulla S, Cordovani D, Downey K, Ye XY, Farine D, Morais M, Balki M.
Anaesthesia. 2022 Aug;77(8):892-900. doi: 10.1111/anae.15714. Epub 2022 Mar 28.
Point-of-Care Diagnostics in Coagulation Management.
Sahli SD, Rössler J, Tscholl DW, Studt JD, Spahn DR, Kaserer A.
Sensors (Basel). 2020 Jul 30;20(15):4254. doi: 10.3390/s20154254.
Point-of-Care Coagulation Testing in Cardiac Surgery.
Bolliger D, Tanaka KA.
Semin Thromb Hemost. 2017 Jun;43(4):386-396. doi: 10.1055/s-0037-1599153. Epub 2017 Mar 30.
Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial.
Yassi N, Zhao H, Churilov L, Wu TY, Ma H, Nguyen HT, Cheung A, Meretoja A, Mai DT, Kleinig T, Jeng JS, Choi PMC, Duc PD, Brown H, Ranta A, Spratt N, Cloud GC, Wang HK, Grimley R, Mahawish K, Cho DY, Shah D, Nguyen TMP, Sharma G, Yogendrakumar V, Yan B, Harrison EL, Devlin M, Cordato D, Martinez-Majander N, Strbian D, Thijs V, Sanders LM, Anderson D, Parsons MW, Campbell BCV, Donnan GA, Davis SM; STOP-MSU Trial Investigators.
Lancet Neurol. 2024 Jun;23(6):577-587. doi: 10.1016/S1474-4422(24)00128-5. Epub 2024 Apr 20.
Prophylactic tranexamic acid for reducing intraoperative blood loss during cesarean section in women at high risk of postpartum hemorrhage: A double-blind placebo randomized controlled trial.
Ortuanya KE, Eleje GU, Ezugwu FO, Odugu BU, Ikechebelu JI, Ugwu EO, Eke AC, Awkadigwe FI, Ezenwaeze MN, Ofor IJ, Okafor CC, Okafor CG.
Womens Health (Lond). 2024 Jan-Dec;20:17455057231225311. doi: 10.1177/17455057231225311.
